These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37693438)

  • 1. In Vivo Antiviral Efficacy of LCTG-002, a Pooled, Purified Human Milk Secretory IgA product, Against SARS-CoV-2 in a Murine Model of COVID-19.
    Mane V; Mehta R; Alvarez N; Sharma V; Park S; Fox A; DeCarlo C; Yang X; Perlin DS; Powell RLR
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19.
    Mane V; Mehta R; Alvarez N; Sharma V; Park S; Fox A; DeCarlo C; Yang X; Perlin DS; Powell RLR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2303226. PubMed ID: 38251677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Secretory IgA Response in Human Milk Against the SARS-CoV-2 Spike Is Highly Durable and Neutralizing for At Least 1 Year of Lactation Postinfection.
    Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
    Breastfeed Med; 2023 Aug; 18(8):602-611. PubMed ID: 37615565
    [No Abstract]   [Full Text] [Related]  

  • 4. The secretory IgA (sIgA) response in human milk against the SARS-CoV-2 Spike is highly durable and neutralizing for at least 1 year of lactation post-infection.
    Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
    medRxiv; 2023 May; ():. PubMed ID: 37293109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk.
    Fox A; Marino J; Amanat F; Krammer F; Hahn-Holbrook J; Zolla-Pazner S; Powell RL
    iScience; 2020 Nov; 23(11):101735. PubMed ID: 33134887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
    Fox A; Marino J; Amanat F; Oguntuyo KY; Hahn-Holbrook J; Lee B; Zolla-Pazner S; Powell RL
    PLoS One; 2022; 17(3):e0249723. PubMed ID: 35263323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women.
    Demers-Mathieu V; Hakansson AP; Hall S; Lavangnananda S; Fels S; Medo E
    Breastfeed Med; 2022 Feb; 17(2):163-172. PubMed ID: 34809492
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.
    Tsukinoki K; Yamamoto T; Handa K; Iwamiya M; Saruta J; Ino S; Sakurai T
    PLoS One; 2021; 16(11):e0249979. PubMed ID: 34813596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines.
    Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL
    Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a colloidal gold-based immunochromatographic assay for rapid detection of nasal mucosal secretory IgA against SARS-CoV-2.
    Sun B; Chen Z; Feng B; Chen S; Feng S; Wang Q; Niu X; Zhang Z; Zheng P; Lin M; Luo J; Pan Y; Guan S; Zhong N; Chen L
    Front Microbiol; 2024; 15():1386891. PubMed ID: 38881666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Persistence of Specific Immunoglobulin A Against SARS-CoV-2 in Human Milk After Maternal COVID-19 Vaccination.
    Suteerojntrakool O; Mekangkul E; Ananta P; Maitreechit D; Khabuan S; Sodsai P; Hirankarn N; Thumbovorn R; Chomtho S
    Breastfeed Med; 2023 Dec; 18(12):943-950. PubMed ID: 38100444
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion.
    Pieri M; Maniori MA; Shahabian L; Kanaan E; Paphiti-Demetriou I; Pipis S; Felekkis K; Nicolaidou V; Papaneophytou C
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 14. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination.
    Ware J; McElhinney K; Latham T; Lane A; Dienger-Stambaugh K; Hildeman D; Spearman P; Ware RE
    Breastfeed Med; 2023 Aug; 18(8):612-620. PubMed ID: 37615566
    [No Abstract]   [Full Text] [Related]  

  • 16. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-binding Domain Severe Acute Respiratory Syndrome Coronavirus 2-specific Antibodies in Human Milk From Mothers With Coronavirus Disease 2019 Polymerase Chain Reaction or With Symptoms Suggestive of Coronavirus Disease 2019.
    Demers-Mathieu V; DaPra C; Fels S; Medo E
    J Pediatr Gastroenterol Nutr; 2021 Jul; 73(1):125-128. PubMed ID: 33938523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding.
    Sajadi MM; Shokatpour N; Purcell M; Tehrani ZR; Lankford A; Bathula A; Campbell JD; Hammershaimb EA; Deatrick KB; Bor C; Parsell DM; Dugan C; Levine AR; Ramelli SC; Chertow DS; Herr DL; Saharia KK; Lewis GK; Grazioli A
    PLoS One; 2023; 18(4):e0284020. PubMed ID: 37023025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.
    Demers-Mathieu V; DaPra C; Medo E
    Breastfeed Med; 2021 May; 16(5):393-401. PubMed ID: 33835835
    [No Abstract]   [Full Text] [Related]  

  • 20. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
    Demers-Mathieu V; Do DM; Mathijssen GB; Sela DA; Seppo A; Järvinen KM; Medo E
    J Perinatol; 2021 Apr; 41(4):850-859. PubMed ID: 32873904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.